会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • Feline IL-18 proteins
    • 猫IL-18蛋白
    • US07928197B2
    • 2011-04-19
    • US12128440
    • 2008-05-28
    • Ramani S. Wonderling
    • Ramani S. Wonderling
    • C07K14/435C07K14/46C07K14/54
    • C12N9/6475A61K38/00A61K48/00C07K14/54C07K14/5434C07K2319/00C12Y304/22036
    • The present invention relates to canine and feline proteins. In particular, the present invention discloses feline interleukin-18, feline caspase-1, feline interleukin-12 single chain and canine interleukin-12 single chain proteins. The present invention also includes feline interleukin-18, feline caspase-1, feline interleukin-12 single chain and canine interleukin-12 single chain nucleic acid molecules encoding such proteins, antibodies raised against such proteins and/or inhibitors of such proteins or nucleic acid molecules. The present invention also includes therapeutic compositions comprising such nucleic acid molecules, proteins, antibodies and/or inhibitors, as well as their use to evaluate and regulate an immune response in an animal.
    • 本发明涉及犬和猫科动物蛋白。 特别地,本发明公开了白细胞介素-18,猫半胱天冬酶-1,猫白细胞介素-12单链和犬白介素-12单链蛋白。 本发明还包括编码这种蛋白质的白细胞介素-18,猫半胱天冬酶-1,猫白细胞介素-12单链和犬白细胞介素-12单链核酸分子,针对这种蛋白产生的抗体和/或这种蛋白质或核酸的抑制剂 分子。 本发明还包括包含这种核酸分子,蛋白质,抗体和/或抑制剂的治疗组合物,以及它们在动物中评价和调节免疫应答的用途。
    • 2. 发明授权
    • Feline IL-18 nucleic acid molecules
    • 猫IL-18核酸分子
    • US07556963B2
    • 2009-07-07
    • US11514728
    • 2006-09-01
    • Ramani S. Wonderling
    • Ramani S. Wonderling
    • C12N15/00C12N15/11C12N15/12
    • C12N9/6475A61K38/00A61K48/00C07K14/54C07K14/5434C07K2319/00C12Y304/22036
    • The present invention relates to canine and feline proteins. In particular, the present invention discloses feline interleukin-18, feline caspase-1, feline interleukin-12 single chain and canine interleukin-12 single chain proteins. The present invention also includes feline interleukin-18, feline caspase-1, feline interleukin-12 single chain and canine interleukin-12 single chain nucleic acid molecules encoding such proteins, antibodies raised against such proteins and/or inhibitors of such proteins or nucleic acid molecules. The present invention also includes therapeutic compositions comprising such nucleic acid molecules, proteins, antibodies and/or inhibitors, as well as their use to evaluate and regulate an immune response in an animal.
    • 本发明涉及犬和猫科动物蛋白。 特别地,本发明公开了白细胞介素-18,猫半胱天冬酶-1,猫白细胞介素-12单链和犬白介素-12单链蛋白。 本发明还包括编码这种蛋白质的白细胞介素-18,猫半胱天冬酶-1,猫白细胞介素-12单链和犬白细胞介素-12单链核酸分子,针对这种蛋白产生的抗体和/或这种蛋白质或核酸的抑制剂 分子。 本发明还包括包含这种核酸分子,蛋白质,抗体和/或抑制剂的治疗组合物,以及它们在动物中评价和调节免疫应答的用途。
    • 7. 发明申请
    • Relatedness of human interleukin-1beta convertase gene to a C. elegans cell death gene, inhibitory portions of these genes and uses therefor
    • 人白细胞介素-1β转化酶基因与线虫细胞死亡基因的相关性,这些基因的抑制部分及其用途
    • US20020136714A1
    • 2002-09-26
    • US09888243
    • 2001-06-22
    • H. Robert HorvitzJunying YuanShai Shaham
    • A61K038/48C12N009/64C12P021/02C12N005/06
    • C12N9/641A61K38/00C07K14/43581C07K14/4747C07K2319/00C12N9/6475C12Q1/6876C12Q2600/156C12Y304/22036C12Y304/22055
    • Described herein is the discovery that human interleukin-1null convertase (ICE) is structurally similar to the protein encoded by the C. elegans cell death gene, ced-3. Comparative and mutational analyses of the two proteins, together with previous observations, suggest that the Ced-3 protein may be a cysteine protease like ICE and that ICE may be a human equivalent of the nematode cell death gene. Another mammalian protein, the murine NEDD-2 protein, was also found to be similar to Ced-3. The NEDD-2 gene is implicated in the development of the murine central nervous system. On the basis of these findings, novel drugs for enhancing or inhibiting the activity of ICE, ced-3, or related genes are provided. Such drugs may be useful for treating inflammatory diseases and/or diseases characterized by cell deaths, as well as cancers, autoimmune disorders, infections, and hair growth and hair loss. Furthermore, such drugs may be useful for controlling pests, parasites and genetically engineered organisms. Furthermore, novel inhibitors of the activity of ced-3, ICE and related genes are described which comprise portions of the genes or their encoded products.
    • 本文描述了人白细胞介素-1β转化酶(ICE)在结构上类似于由线虫类细胞死亡基因ced-3编码的蛋白质的发现。 两种蛋白质的比较和突变分析结合以前的观察结果表明,Ced-3蛋白可能是像ICE这样的半胱氨酸蛋白酶,并且ICE可能是人类等效于线虫细胞死亡基因。 还发现另一种哺乳动物蛋白,鼠类NEDD-2蛋白质与Ced-3相似。 NEDD-2基因涉及鼠中枢神经系统的发展。 在这些发现的基础上,提供了用于增强或抑制ICE,ced-3或相关基因活性的新型药物。 这些药物可用于治疗以细胞死亡为特征的炎性疾病和/或疾病,以及癌症,自身免疫性疾病,感染和毛发生长和脱发。 此外,这些药物可用于控制害虫,寄生虫和遗传工程生物体。 此外,描述了包含部分基因或其编码产物的ced-3,ICE和相关基因的活性的新型抑制剂。
    • 8. 发明申请
    • FELINE IL-18 PROTEINS
    • FELINE IL-18蛋白
    • US20090198043A1
    • 2009-08-06
    • US12128440
    • 2008-05-28
    • RAMANI S. WONDERLING
    • RAMANI S. WONDERLING
    • C07K14/54
    • C12N9/6475A61K38/00A61K48/00C07K14/54C07K14/5434C07K2319/00C12Y304/22036
    • The present invention relates to canine and feline proteins. In particular, the present invention discloses feline interleukin-18, feline caspase-1, feline interleukin-12 single chain and canine interleukin-12 single chain proteins. The present invention also includes feline interleukin-18, feline caspase-1, feline interleukin-12 single chain and canine interleukin-12 single chain nucleic acid molecules encoding such proteins, antibodies raised against such proteins and/or inhibitors of such proteins or nucleic acid molecules. The present invention also includes therapeutic compositions comprising such nucleic acid molecules, proteins, antibodies and/or inhibitors, as well as their use to evaluate and regulate an immune response in an animal.
    • 本发明涉及犬和猫科动物蛋白。 特别地,本发明公开了白细胞介素-18,猫半胱天冬酶-1,猫白细胞介素-12单链和犬白介素-12单链蛋白。 本发明还包括编码这种蛋白质的白细胞介素-18,猫半胱天冬酶-1,猫白细胞介素-12单链和犬白细胞介素-12单链核酸分子,针对这种蛋白产生的抗体和/或这种蛋白质或核酸的抑制剂 分子。 本发明还包括包含这种核酸分子,蛋白质,抗体和/或抑制剂的治疗组合物,以及它们在动物中评价和调节免疫应答的用途。